Testing the Effectiveness of the Her Health Program to Add Healthcare Value in the Fourth Trimester (Her Health)

March 25, 2025 updated by: Elizabeth F Sutton, PhD

The goal of this clinical trial is to learn if a program Woman's Hospital has made, called the Her Health Program, can help women be healthy and get healthcare in the first year after having a baby.

The main question[s] the study aims to answer are:

  • Can the Her Health program increase access to healthcare in the first year postpartum?
  • Can the Her Health program increase knowledge about healthcare and change feelings toward the healthcare system?

Participants will complete one research visit in which they will be enrolled and told which group they will be in- "Her Health Program" group or "Usual Care" group. If they are placed in the "Her Health Program" group, they will receive their usual care + the addition of an extra healthcare team member(called a community health navigator) to to work with patients and care team for a year postpartum.

Researchers will compare those who receive the Her Health Program and those who do not receive the program to see if the Her Health Program can help women get healthcare in the first year after having a baby.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Louisiana
      • Baton Rouge, Louisiana, United States, 70817
        • Woman's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • At least 16 years old at the time of consent.
  • Gave birth within 7 days before randomization
  • Medicaid enrolled
  • Address of residence within a disadvantaged area (ADI>5).
  • Clearly understands the study procedures and visit schedule, alternative treatments, and risks involved with the study, and voluntarily agrees to participate by giving verbal and written informed consent

Exclusion Criteria:

  • Use of private health insurance exclusively
  • Does not speak English.
  • Plans to move out of state during the study time period
  • Unwilling to provide permission to link study records, medical records, and Medicaid and Vital Records Database records.
  • Unwilling to provide informed consent
  • Unwilling to be randomized.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
Subjects will see doctors as normal during first year postpartum with no assistance.
Experimental: Her Health Program
Her Health is a patient navigation intervention delivered by community health workers across the first postpartum year. Her Health has two interspersed components: Navigation and Education. Her Health Navigation is delivered through weekly and monthly check-ins between participant and navigator. Her Health navigators will deliver historically informed and culturally competent education designed to promote self-efficacy and self-advocacy within the healthcare system.
Addition of a community health worker navigator to assist subject in navigating their health in the first year postpartum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum visit attendance
Time Frame: 12 weeks postpartum
Visit attended between 6-12 weeks of delivery (yes/no)
12 weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medical trust
Time Frame: 12 months postpartum
Group-Based Medical Mistrust Scale; scores range from 12-60 with higher scores indicating more mistrust
12 months postpartum
Health literacy
Time Frame: 12 months postpartum
Rapid Estimate of Adult Literacy in Medicine (REALM); scores 0-66; higher score indicates high literacy
12 months postpartum
Self-efficacy
Time Frame: 12 months postpartum
PROMIS General Self-Efficacy; scores range 5-50; higher score indicates higher self-efficacy
12 months postpartum
Healthcare costs
Time Frame: 12 months postpartum
total cost of healthcare from Medicaid Claims Database within the first 12 months after delivery
12 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth Sutton, PhD, Woman's Hospital, Louisiana

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 29, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

February 8, 2024

First Submitted That Met QC Criteria

February 29, 2024

First Posted (Actual)

March 7, 2024

Study Record Updates

Last Update Posted (Actual)

March 26, 2025

Last Update Submitted That Met QC Criteria

March 25, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • RP-23-019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Her Health Program

Subscribe